Antiviral combination therapies for persistent COVID-19 in immunocompromised patients. Focosi D, Maggi F, D'Abramo A, Nicastri E, et al. Int J Infect Dis 2023 Sep 29:S1201-9712(23)00734.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Focosi D, Maggi F, D'Abramo A, Nicastri E, et al. Antiviral combination therapies for persistent COVID-19 in immunocompromised patients. Int J Infect Dis 2023 Sep 29:S1201-9712(23)00734.
PMID: 37778409